Benzodiazepines a ‘high-risk’ treatment for amphetamine use disorder
Antidepressants and antipsychotics are also tied to an increased risk of poor outcomes, Swedish cohort study shows
Benzodiazepine treatment in patients with methamphetamine or amphetamine use disorder is linked to a higher risk of death and hospitalisation than other pharmacotherapies, research shows.
Results from a Swedish nationwide cohort study suggest antidepressants and antipsychotics also lead to poor outcomes in these patients, who already have a higher mortality risk compared with the general population.
